SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001554795-14-000153
Filing Date
2014-03-04
Accepted
2014-03-04 16:03:10
Documents
1
Period of Report
2014-03-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A gnbt030314sched14a.htm PRE 14A 570126
  Complete submission text file 0001554795-14-000153.txt   571163
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: PRE 14A | Act: 34 | File No.: 000-25169 | Film No.: 14664639
SIC: 2834 Pharmaceutical Preparations